Navidea Biopharmaceuticals - 28 Year Stock Price History | NAVB
Historical daily share price chart and data for Navidea Biopharmaceuticals since 1992 adjusted for splits. The latest closing stock price for Navidea Biopharmaceuticals as of June 05, 2020 is 3.20.
- The all-time high Navidea Biopharmaceuticals stock closing price was 432.50 on February 21, 1996.
- The Navidea Biopharmaceuticals 52-week high stock price is 3.50, which is 9.4% above the current share price.
- The Navidea Biopharmaceuticals 52-week low stock price is 0.49, which is 84.7% below the current share price.
- The average Navidea Biopharmaceuticals stock price for the last 52 weeks is 0.93.
| Navidea Biopharmaceuticals Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2020 | 1.1715 | 1.2900 | 3.2000 | 0.7000 | 3.2000 | 153.97% |
| 2019 | 1.5742 | 2.2940 | 3.6000 | 0.5000 | 1.2600 | -38.66% |
| 2018 | 5.1365 | 7.7800 | 8.1980 | 2.0540 | 2.0540 | -71.35% |
| 2017 | 9.5384 | 12.9260 | 15.4620 | 6.8740 | 7.1700 | -43.76% |
| 2016 | 16.8253 | 25.8000 | 30.0000 | 6.0000 | 12.7500 | -52.07% |
| 2015 | 33.8508 | 38.6000 | 48.2000 | 24.8000 | 26.6000 | -29.63% |
| 2014 | 30.9714 | 40.0000 | 41.2000 | 20.4000 | 37.8000 | -8.70% |
| 2013 | 51.8183 | 57.6000 | 68.2000 | 28.0000 | 41.4000 | -26.86% |
| 2012 | 62.1328 | 54.8000 | 93.6000 | 43.8000 | 56.6000 | 8.02% |
| 2011 | 65.4746 | 42.4000 | 109.6000 | 39.0000 | 52.4000 | 27.18% |
| 2010 | 36.5064 | 23.4000 | 43.4000 | 23.4000 | 41.2000 | 68.85% |
| 2009 | 18.5474 | 11.2200 | 28.0000 | 9.0000 | 24.4000 | 114.04% |
| 2008 | 10.6386 | 6.4000 | 16.8000 | 6.4000 | 11.4000 | 99.30% |
| 2007 | 5.3311 | 5.0000 | 9.8000 | 3.8000 | 5.7200 | 19.17% |
| 2006 | 5.5200 | 5.0000 | 7.2000 | 4.6000 | 4.8000 | -2.04% |
| 2005 | 7.5133 | 12.0000 | 13.8000 | 4.9000 | 4.9000 | -58.12% |
| 2004 | 10.2239 | 6.4000 | 20.0000 | 5.8000 | 11.7000 | 88.71% |
| 2003 | 4.0492 | 2.6000 | 9.5000 | 2.0320 | 6.2000 | 138.46% |
| 2002 | 5.2536 | 8.4000 | 10.0000 | 1.5000 | 2.6000 | -69.05% |
| 2001 | 10.2726 | 8.1200 | 18.4000 | 7.0000 | 8.4000 | 0.00% |
| 2000 | 17.5417 | 9.0000 | 60.0000 | 7.5000 | 8.4000 | -3.89% |
| 1999 | 14.4229 | 17.5000 | 36.2600 | 6.2000 | 8.7400 | -39.20% |
| 1998 | 59.1139 | 127.5000 | 127.5000 | 10.0000 | 14.3760 | -88.02% |
| 1997 | 261.0421 | 302.6000 | 357.6000 | 120.0000 | 120.0000 | -60.99% |
| 1996 | 327.0848 | 315.0000 | 432.5000 | 215.0000 | 307.6000 | -4.65% |
| 1995 | 165.0156 | 30.0000 | 398.2000 | 30.0000 | 322.6000 | 975.33% |
| 1994 | 88.4839 | 123.7600 | 145.0000 | 23.7600 | 30.0000 | -76.00% |
| 1993 | 121.7964 | 122.5000 | 155.0000 | 105.0000 | 125.0000 | 4.17% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.062B | $0.001B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $137.502B | 27.92 |
| Intuitive Surgical (ISRG) | United States | $65.802B | 48.60 |
| Edwards Lifesciences (EW) | United States | $43.996B | 36.98 |
| DexCom (DXCM) | United States | $31.845B | 148.64 |
| ALCON INC (ALC) | Switzerland | $31.176B | 34.90 |
| IDEXX Laboratories (IDXX) | United States | $26.336B | 62.02 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $25.817B | 17.59 |
| Olympus (OCPNY) | Japan | $25.321B | 51.50 |
| Teleflex (TFX) | United States | $17.020B | 31.52 |
| Sysmex ADR (SSMXY) | Japan | $15.808B | 44.55 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.112B | 0.00 |
| STERIS (STE) | Ireland | $13.640B | 28.48 |
| Hologic (HOLX) | United States | $13.509B | 21.27 |
| Masimo (MASI) | United States | $11.830B | 64.30 |
| Varian Medical Systems (VAR) | United States | $11.543B | 28.00 |
| ABIOMED (ABMD) | United States | $10.611B | 57.01 |
| SARTORIUS AG (SARTF) | Germany | $10.264B | 88.24 |
| Penumbra (PEN) | United States | $6.129B | 236.12 |
| Globus Medical (GMED) | United States | $5.145B | 32.56 |
| Tandem Diabetes Care (TNDM) | United States | $4.648B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $4.477B | 20.53 |
| Nevro (NVRO) | United States | $4.132B | 0.00 |
| Wright Medical Group (WMGI) | Netherlands | $3.828B | 594.00 |
| Elekta AB (EKTAY) | Sweden | $3.824B | 29.44 |
| Nihon Kohden (NHNKY) | Japan | $2.925B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.696B | 16.65 |
| LivaNova (LIVN) | United Kingdom | $2.636B | 19.88 |
| Cantel Medical (CMD) | United States | $2.034B | 23.30 |
| Glaukos (GKOS) | United States | $1.890B | 0.00 |
| OPKO Health (OPK) | United States | $1.521B | 0.00 |
| Luminex (LMNX) | United States | $1.414B | 0.00 |
| ShockWave Medical (SWAV) | United States | $1.400B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.380B | 26.76 |
| Veracyte (VCYT) | United States | $1.256B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.206B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $1.095B | 57.96 |
| Tactile Systems Technology (TCMD) | United States | $0.969B | 122.88 |
| CryoLife (CRY) | United States | $0.889B | 123.95 |
| OrthoPediatrics (KIDS) | United States | $0.844B | 0.00 |
| Inogen (INGN) | United States | $0.840B | 50.15 |
| Natus Medical (NTUS) | United States | $0.770B | 18.98 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.681B | 27.50 |
| GenMark Diagnostics (GNMK) | United States | $0.594B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.579B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.560B | 0.00 |
| Si-Bone (SIBN) | United States | $0.506B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.471B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.398B | 26.48 |
| AxoGen (AXGN) | United States | $0.398B | 0.00 |
| Intersect ENT (XENT) | United States | $0.386B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.347B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.336B | 0.00 |
| Vermillion (VRML) | United States | $0.321B | 0.00 |
| Stereotaxis (STXS) | United States | $0.321B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.309B | 0.00 |
| ViewRay (VRAY) | United States | $0.308B | 0.00 |
| TransMedics (TMDX) | United States | $0.303B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.278B | 30.80 |
| IRadimed (IRMD) | United States | $0.273B | 29.44 |
| Fluidigm (FLDM) | United States | $0.272B | 0.00 |
| Accuray (ARAY) | United States | $0.221B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.216B | 58.60 |
| Sientra (SIEN) | United States | $0.191B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.160B | 111.50 |
| T2 Biosystems (TTOO) | United States | $0.141B | 0.00 |
| Electromed (ELMD) | United States | $0.132B | 33.76 |
| Restoration Robotics (VERO) | Canada | $0.109B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.100B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.076B | 37.29 |
| MRI Interventions (CLPT) | United States | $0.066B | 0.00 |
| ConforMIS (CFMS) | United States | $0.064B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.058B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.050B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.044B | 0.00 |
| TransEnterix (TRXC) | United States | $0.041B | 0.00 |
| Neovasc (NVCN) | Canada | $0.038B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.038B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.034B | 0.00 |
| Neuronetics (STIM) | United States | $0.034B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.029B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.022B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.022B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.022B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.020B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.019B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.018B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.016B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.013B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.012B | 40.80 |
| Dynatronics (DYNT) | United States | $0.010B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.010B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.008B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.008B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.007B | 0.00 |
| InspireMD (NSPR) | Israel | $0.002B | 0.00 |
